The EU-FMD clock is ticking!

This article examines key requirements of the “Safety Features” Delegated Regulation and discusses the implications for pharmaceutical manufacturers and other participants in the European pharmaceutical supply chain.

Issue 28- March 2016
Industry Pharmacy

Read Now

 

Pharmaceutical Commerce Magazine invites you to view this free webinar: Serialization Lessons from the Front Lines of Distribution

Join subject matter experts from AmerisourceBergen, Excellis Health Solutions and Acsis as we discuss the next phase of the DSCSA requirements, with a focus on warehousing and distribution. In this webinar, moderated by Pharmaceutical Commerce, we will review where our industry is today on the journey toward full DSCSA compliance and how companies can benefit from going beyond compliance.

(more…)

EHS/PDA Webinar: Managing Global Serialization Program Rollouts

Learn about DSCSA and other global regulatory requirements impacting the industry and specifically, your company from 2015-2023. Find out how these regulations can help transform business processes across your enterprise. CEO of Excellis Health Solutions, Greg Cathcart, will be leading a discussion on gaining a perspective on the latest global regulations and planning and implementing your Global Serialization Initiative. The interactive presentation will offer best practices and strategies for updated serialization programs.

When: December 15, 2015
Time: 1:00 pm
Who: Greg Cathcart, Excellis Health Solutions CEO
Where: Webex


For more details, click here.

MHRA Informs About Huge Counterfeit Case

The Medicines and Healthcare Products Regulatory Agency (MHRA) published a press release about a huge counterfeit case in the United Kingdom. Fake medicinal products that were estimated to be worth around 15.8 million British Pounds, has been seized in the UK.

This operation–dubbed “Pangea VIII”–was coordinated by Interpol and has lead to 156 arrests worldwide, according to GMP News.

Source: GMP News